Global Pharmaceutical Logistics Market Assessment, By Type [Cold Chain Logistics, Non-Cold Chain Logistics], By Procedure [Picking, Storage, Retrieval Systems, Handling Systems], By Component [Storage, Transportation, Monitoring Component], By Application [Chemical Pharma, Biopharma, Specialized Pharma], By Operation [Seaways, Roadways, Railways, Airways, Storage and Services], By Region, Opportunities and Forecast, 2018-2032F

Global Pharmaceutical Logistics Market is projected to witness a CAGR of 8.82% during the forecast period 2024-2032, growing from USD 103.75 billion in 2024 to USD 204.02 billion in 2032.

The pharmaceutical logistics market is poised for significant growth, driven by various factors, including the increasing prevalence of online pharmacy orders and a rise in seaborne pharmaceutical transportation. These developments are crucial as they enhance the efficiency of logistics networks within the healthcare sector. The growing emphasis on cold chain logistics initiatives is also expected to propel market expansion further.

Several factors drive this growth, including the overall mushrooming of the pharmaceutical industry, a growing demand for reverse logistics, and an upsurge in international trade activities. However, some challenges need to be overcome, such as a lack of standardization in pharmaceutical logistics and storage, a lack of infrastructure, and high logistics costs that may affect market development over the forecast period.

To respond to the changing demand pattern, market players focus on expanding their footprint geographically and exploring new business opportunities. In contrast to the other logistics sectors, pharmaceutical logistics is exclusive as it only caters to hospitals, clinics, pharmacies, and other healthcare centers with strict storage requirements, such as temperature and humidity conditions. Key players in this chain include value-added suppliers of raw materials and packaging, storage logistics service providers who are, in most cases, central warehouses and stockists, healthcare facilities, retail, pharmacies, and end customers. As the landscape continues to evolve, so does the potential for growth that pharmaceutical logistics shall respond to owing to increasing global needs.

For instance, in August 2024, Otsuka Pharmaceutical partnered with the Tokyo Government for the Sustainable Aviation Fuel (SAF) Promotion Project. As a result of this strategic partnership with Yusen Logistics Co., Ltd, Otsuka will consign its pharmaceutical shipments to the United States, contributing to the project. Using SAF for pharmaceutical shipments, Otsuka seeks to contribute to the greening of its supply chain and to demonstrate its corporate social responsibility.

Increasing Demand for Over-The-Counter Medications Leads Logistics Growth

"Over the counter" (OTC) is a term used to denote drugs that do not require a prescription from a doctor and can be procured through pharmacies or even online. When taken as directed on the package, these drugs are effective and safe. Growth in demand is likely to occur most rapidly in China, India, Brazil, and South Africa. This growth can be attributed to several factors, including rapid population increases, a higher prevalence of diseases and infections, a growing trend toward self-medication, and easier access to OTC products through pharmacies and retail stores. In developed countries such as the United States, OTC medications are a common sight in nearly every pharmacy, often serving as the first line of treatment for minor health concerns. A major growth driver in the market during the forecast period is the growing trend of self-medication. Another reason for market expansion is the transition from prescription to OTC medicines, usually for economic reasons, and new products for enhancing immunity, which have recently entered the market. Ease of access and low cost are key factors behind this growth.

In recent years, obesity medicines, which are primarily sold over the counter, have experienced a high growth trend globally. During the third quarter of 2024, Novo Nordisk's obesity drug sold at approximately USD 2.5 billion, about 81% more than the sales of the same in the third quarter of 2023.

Growth of E-Commerce in the Healthcare Sector Drives the Market Growth

In the recent past, healthcare e-commerce experienced a tremendous boom all over the world. This has been mainly attributed to the demand for convenience due to the rising tendency of consumers to opt for online sources for their health needs. User experience has also been enhanced by the integration of telemedicine, personalized healthcare solutions, and AI-driven recommendations, hence contributing to considerable market expansion.

With the rapid growth in healthcare e-commerce, logistics companies have had to innovate and extend their services to match the sector's needs. Like this, AI, robotics, and IoT help optimize logistics functions so that goods can be delivered on time with minimal hassle. With healthcare e-commerce in motion, e-commerce platforms will collaborate with logistics companies to ensure the delivery of smooth and effective solutions for the demand for global health.

For instance, in January 2025, Ethiopian Airlines announced the recertification of IATA CEIV Pharma (Center of Excellence for Independent Validators in Pharmaceutical Logistics) accreditation as an airline and ground handling agent. They also aim to make Addis Ababa the premier Pharma corridor in the global south, leveraging its strategic location to address the logistical challenges of healthcare air transportation. This will allow them to reach and explore new potential areas.

Widespread Adoption of Cutting-edge Technologies in Pharmaceutical Logistics

The integration of digital technology into pharmaceutical logistics has transformed the industry as it has been increasing drug safety, enhancing productivity, and streamlining processes with leading-edge technologies. This includes machine learning, big data, and automation tools, which have enhanced visibility and control throughout the supply chain. Many logistics providers are currently using automated storage and retrieval systems to meet multiple customer needs. These systems are used in manufacturing, distribution, and warehouse operations to manage inventory effectively, with advanced machinery that can move along multiple pathways.

The efficiency of various operations is further boosted by the implementation of warehouse execution software and warehouse management systems, which reduce human error through intelligent systems. The introduction of blockchain technology in logistics also brings a new level of transparency into the system, ensuring that drug information remains secure and authentic throughout the supply chain.

In August 2024, Federal Express Corporation announced the release of its innovative FedEx Surround, an intelligent solution for monitoring and intervention designed to elevate logistics and supply chain management by enhancing control and visibility of shipments for customers. FedEx Surround provides customers three key benefits that enhance logistics and supply chain management. It offers flexibility and control through a dashboard that delivers near real-time global visibility and predictive analytics using AI and SenseAware ID. It also enables customers to keep track of their shipments closely and to make the best decisions possible.

The dominance of the Storage Segment in Components Leads Pharmaceutical Logistics Market

There is a storage component dominance in the pharmaceutical logistics market due to the increasing demand for generic and branded pharmaceutical medicines. The growth necessitates the provision of sound storage facilities that help maintain the effectiveness of the products post-manufacturing and throughout the entire supply chain distribution process to channels, including distributors and retailers. Such drugs as vaccines and biologics require cold storage solutions to ensure their efficacy, and the spread of COVID-19 has intensified this requirement to highlight the urgency of dependable temperature-controlled storage facilities. Further demand for such innovative storage solutions stems from changes in consumer lifestyles and dietary habits, leading to an increase in the requirement for temperature-sensitive nutritional supplements.

While transportation in pharmaceutical logistics is also expected to grow rapidly, the storage component remains foundational to ensuring that medications are stored properly before they reach patients. As the market evolves, investments in both cold chain capabilities and innovative storage solutions will be essential for meeting the increasing demands of the pharmaceutical industry.

For instance, in Jan 2024, AbbVie strengthened its manufacturing capabilities by breaking ground on a new USD 223 million (SGD 301 million) expansion of its Singapore manufacturing facility. This new investment will add 24,000 litres of biologics drug-substance capacity to AbbVie's global manufacturing network and support current products, 100 jobs, and new biologics manufacturing capacity to AbbVie's global network as well as emerging immunology and oncology compounds within AbbVie's pipeline.

Europe Dominates Pharmaceutical Logistics Market Share

Europe is the largest market for pharmaceutical logistics globally, driven by a few key factors that enhance its capacity to meet increasing demands for pharmaceutical products. In this regard, the region is considering incorporating innovative technologies in pharmacy logistics, such as the Internet of Things (IoT), track-and-trace systems, and real-time data analytics. These technologies have positively transformed logistics operations by enhancing visibility, making them efficient and controlled, and managing supply chains. Strong logistics systems in place are required for the efficient delivery on time and storage of medicinal products since high pharmaceutical consumption in Europe is due to an aging population and increasingly more prevalent chronic diseases.

The pharmaceutical industry's high investments in research and development also boost demand for logistics that must often be temperature-sensitive and innovative biopharmaceutical products. Europe boasts extensive infrastructure, such as transportation and more modern warehouses, which promote efficient pharmaceutical logistics operations. Moreover, successful pharmaceutical manufacturers located in Germany, the United Kingdom, and France prove to be influential factors in why the region is under their command, as their existence will naturally create a competitive environment that drives innovation and quality in services.

For instance, in April 2024, Merck, a leading science and technology company, invested more than USD 311 million (EUR 300 million) in a new research center at its global headquarters in Darmstadt, Germany. Merck also aims to invest around 1.55 billion (EUR 1.5 billion) in total by 2025.

Germany is the leading pharmaceutical innovation location in Europe and is among the world's leading clinical trial locations based on R&D investment and patent application levels.

Download Free Sample Report

Future Market Scenario (2025 – 2032F)

• The demand for cold chain logistics will be increasing in response to the growing requirement for transporting temperature-sensitive drugs and vaccines.
• The increased adoption of biopharmaceuticals and personalized medicine will continue to fuel the growth of specialized logistics services customized to specific product requirements.
• The U.S. and European markets will continue to dominate, but significant growth is anticipated in Asia-Pacific, particularly in China and India, owing to the expanding pharmaceutical industry in these regions.
• There is a growing emphasis on sustainable and eco-friendly logistics solutions. Companies are focusing on reducing their carbon footprint by adopting green packaging materials and optimizing transportation routes.

Report Scope

“Pharmaceutical Logistics Market Assessment, Opportunities and Forecast, 2018-2032F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of the global Pharmaceutical Logistics market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecasts between 2025 and 2032. Additionally, the report profiles the leading players in the industry, mentioning their respective market share, business models, competitive intelligence, etc.

Report Attribute	Details
Base Year of the Analysis	2024
Historical Period	2018-2023
Forecast Period	2025-2032
Projected Growth Rate	CAGR of 8.82% between 2025 and 2032
Revenue Forecast in 2032	USD 204.02 billion
Segments Covered	Type, Procedure, Component, Application, Operation
Regions Covered	North America, Europe, South America, Asia-Pacific, Middle East and Africa
Key Companies Profile	Kuehne + Nagel International AG und Co., American Airlines, Inc., CEVA Logistics AG, United Parcel Service, Inc., Prompt Brazil Logistics Ltd., Singapore Post Limited, Agility Public Warehousing Company K.S.C.P., DHL International GmbH, Yusen Logistics Co., Ltd., Delhivery Limited
Customization Scope	15% free report customization with purchase
Pricing and Purchase Options	Avail the customized purchase options to fulfill your precise research needs
Delivery Format	PDF and Excel through email (subject to the license purchased)

In the report, global pharmaceutical logistics market has been segmented into the following categories: 

• By Type
  • Cold Chain Logistics
  • Non-Cold Chain Logistics
• By Procedure
  • Picking
  • Storage
  • Retrieval Systems
  • Handling Systems
• By Component
  • Storage
  • Transportation
  • Monitoring Component
• By Application
  • Chemical Pharma
  • Biopharma
  • Specialized Pharma
• By Operation
  • Seaways
  • Roadways
  • Railways
  • Airways
  • Storage and Services
• By Region
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

Key Players Landscape and Outlook

The global pharmaceutical logistics market is characterized by a competitive landscape where top players vie for dominance through several key factors. Technological advancements play a crucial role, with significant investments in AI, blockchain, IoT, and telematics enhancing supply chain transparency, efficiency, and safety. Additionally, cold chain capabilities are vital as the demand for temperature-controlled logistics rises, particularly for biopharmaceuticals and vaccines. The current market conditions reflect a strong emphasis on cold chain logistics due to the rising need for temperature-controlled storage and transportation. Advanced technologies such as RFID and IoT are significantly improving supply chain visibility and operational efficiency. The industry is also witnessing a wave of mergers and acquisitions, as major players consolidate to strengthen their market positions and expand service offerings.

In January 2025, United Parcel Service, Inc. completed the acquisitions of healthcare cold-chain logistics providers Frigo-Trans and BPL. These acquisitions accelerate their plan to provide healthcare customers with end-to-end temperature-controlled solutions across Europe.

In March 2024, Freight Management Holdings Pty Ltd (FMH Group), a subsidiary of Singapore Post Limited Group announced the acquisition of Border Express and the intended merger with CouriersPlease to bring in Growth. This move will expand their network, facilitate innovation and bring in operational excellence.

Key Players Operating in the Global Pharmaceutical Logistics Market are:

• Kuehne + Nagel International AG und Co.
• American Airlines, Inc.
• CEVA Logistics AG
• United Parcel Service, Inc.
• Prompt Brazil Logistics Ltd.
• Singapore Post Limited
• Agility Public Warehousing Company K.S.C.P.
• DHL International GmbH
• Yusen Logistics Co., Ltd.
• Delhivery Limited

Markets and Data’s reports answer the following questions:

• What is the current and future market size of the product/service in question globally or specific to different countries?
• How are the markets divided into different product/service segments and the market size and growth of each segment?
• What is the market potential of different product segments and their investment case?
• How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
• What is the business environment and regulatory landscape specific to the product/service?

If you can't find what you're searching for or have any custom requirements for the global pharmaceutical logistics market, you may approach our team at info@marketsandata.com